Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2009

01.09.2009 | Epidemiology

Low penetrance breast cancer predisposition SNPs are site specific

verfasst von: Niall Mcinerney, Gabrielle Colleran, Andrew Rowan, Axel Walther, Ella Barclay, Sarah Spain, Angela M. Jones, Stephen Tuohy, Catherine Curran, Nicola Miller, Michael Kerin, Ian Tomlinson, Elinor Sawyer

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Large scale association studies have identified low penetrance susceptibility alleles that predispose to breast cancer. A locus on chromosome 8q24.21 has been shown to harbour variants that predispose to breast, ovarian, colorectal and prostate cancer. The finding of risk variants clustering at 8q24 suggests that there may be common susceptibility alleles that predispose to more than one epithelial cancer. The aim of this study was firstly to determine whether previously identified breast cancer susceptibility alleles are associated with sporadic breast cancer in the West of Ireland and secondly to ascertain whether there are susceptibility alleles that predispose to all three common epithelial cancers (breast, prostate, colon). We genotyped a panel of 24 SNPs that have recently been shown to predispose to prostate, colorectal or breast cancer in 988 sporadic breast cancer cases and 1,016 controls from the West of Ireland. We then combined our data with publicly available datasets using standard techniques of meta-analysis. The known breast cancer SNPs rs13281615, rs2981582 and rs3803662 were confirmed as associated with breast cancer risk (P allelic test = 1.8 × 10−2, OR = 1.17; P allelic test = 2.2 × 10−3, OR = 1.22; P allelic test = 5.1 × 10−2, OR = 1.15, respectively) in the West of Ireland cohort. For the remaining five breast cancer SNPs that were studied there was no evidence of an association with breast cancer in the West Ireland population (P allelic test > 6.5 × 10−2). There was also no association between any of the prostate or colorectal susceptibility SNPs, whether at 8q24 or elsewhere, with breast cancer risk. Meta-analysis confirmed that all susceptibility SNPs were site specific, with the exception of rs6983269 which is known to predispose to both colorectal and prostate cancer. This study confirms that susceptibility loci at FGFR2, 8q24 and TNCR9 predispose to sporadic breast cancer in the West of Ireland. It also suggests that low penetrance susceptibility SNPs for breast, prostate and colorectal cancer are distinct. Although 8q24 harbours variants that predispose to all three cancers, the susceptibility loci within the region appear to be specific for the different cancer types with the exception of rs6983269 in colon and prostate cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
4.
Zurück zum Zitat Hunter DJ, Kraft P, Jacobs KB et al (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39(7):870–874. doi:10.1038/ng2075 PubMedCrossRef Hunter DJ, Kraft P, Jacobs KB et al (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39(7):870–874. doi:10.​1038/​ng2075 PubMedCrossRef
5.
Zurück zum Zitat Stacey SN, Manolescu A, Sulem P et al (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39(7):865–869. doi:10.1038/ng2064 PubMedCrossRef Stacey SN, Manolescu A, Sulem P et al (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39(7):865–869. doi:10.​1038/​ng2064 PubMedCrossRef
6.
Zurück zum Zitat Stacey SN, Manolescu A, Sulem P et al (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 40(6):703–706. doi:10.1038/ng.131 PubMedCrossRef Stacey SN, Manolescu A, Sulem P et al (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 40(6):703–706. doi:10.​1038/​ng.​131 PubMedCrossRef
7.
Zurück zum Zitat Driver KE, Song H, Lesueur F et al (2008) Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis 29(2):333–341. doi:10.1093/carcin/bgm284 PubMedCrossRef Driver KE, Song H, Lesueur F et al (2008) Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis 29(2):333–341. doi:10.​1093/​carcin/​bgm284 PubMedCrossRef
8.
Zurück zum Zitat Ma H, Jin G, Hu Z et al (2006) Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women. Int J Cancer 119(9):2173–2178. doi:10.1002/ijc.22094 PubMedCrossRef Ma H, Jin G, Hu Z et al (2006) Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women. Int J Cancer 119(9):2173–2178. doi:10.​1002/​ijc.​22094 PubMedCrossRef
9.
Zurück zum Zitat Amundadottir LT, Sulem P, Gudmundsson J et al (2006) A common variant associated with prostate cancer in European and African populations. Nat Genet 38(6):652–658. doi:10.1038/ng1808 PubMedCrossRef Amundadottir LT, Sulem P, Gudmundsson J et al (2006) A common variant associated with prostate cancer in European and African populations. Nat Genet 38(6):652–658. doi:10.​1038/​ng1808 PubMedCrossRef
10.
Zurück zum Zitat Freedman ML, Haiman CA, Patterson N et al (2006) Admixture mapping identifies 8q24 as a prostate cancer risk locus in African–American men. Proc Natl Acad Sci USA 10338:14068–14073. doi:10.1073/pnas.0605832103 CrossRef Freedman ML, Haiman CA, Patterson N et al (2006) Admixture mapping identifies 8q24 as a prostate cancer risk locus in African–American men. Proc Natl Acad Sci USA 10338:14068–14073. doi:10.​1073/​pnas.​0605832103 CrossRef
11.
Zurück zum Zitat Gudmundsson J, Sulem P, Manolescu A et al (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39(5):631–637. doi:10.1038/ng1999 PubMedCrossRef Gudmundsson J, Sulem P, Manolescu A et al (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39(5):631–637. doi:10.​1038/​ng1999 PubMedCrossRef
12.
13.
15.
Zurück zum Zitat Tomlinson I, Webb E, Carvajal-Carmona L et al (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39(8):984–988. doi:10.1038/ng2085 PubMedCrossRef Tomlinson I, Webb E, Carvajal-Carmona L et al (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39(8):984–988. doi:10.​1038/​ng2085 PubMedCrossRef
16.
Zurück zum Zitat Zanke BW, Greenwood CM, Rangrej J et al (2007) Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 39(8):989–994. doi:10.1038/ng2089 PubMedCrossRef Zanke BW, Greenwood CM, Rangrej J et al (2007) Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 39(8):989–994. doi:10.​1038/​ng2089 PubMedCrossRef
19.
Zurück zum Zitat Houlston RS, Peto J (2004) Genetics and the common cancers. In Eeles RA, Easton DF, Ponder BAJ, Eng C (eds) Genetic predisposition to cancer, 2nd edn, Arnold, London Houlston RS, Peto J (2004) Genetics and the common cancers. In Eeles RA, Easton DF, Ponder BAJ, Eng C (eds) Genetic predisposition to cancer, 2nd edn, Arnold, London
20.
21.
22.
Zurück zum Zitat Gudmundsson J, Sulem P, Rafnar T et al (2008) Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 40(3):281–283. doi:10.1038/ng.89 PubMedCrossRef Gudmundsson J, Sulem P, Rafnar T et al (2008) Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 40(3):281–283. doi:10.​1038/​ng.​89 PubMedCrossRef
23.
24.
Zurück zum Zitat Tenesa A, Farrington SM, Prendergast JG et al (2008) Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 40(5):631–637. doi:10.1038/ng.133 PubMedCrossRef Tenesa A, Farrington SM, Prendergast JG et al (2008) Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 40(5):631–637. doi:10.​1038/​ng.​133 PubMedCrossRef
25.
Zurück zum Zitat Broderick P, Carvajal-Carmona L, Pittman AM et al (2007) A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet 39(11):1315–1317. doi:10.1038/ng.2007.18 PubMedCrossRef Broderick P, Carvajal-Carmona L, Pittman AM et al (2007) A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet 39(11):1315–1317. doi:10.​1038/​ng.​2007.​18 PubMedCrossRef
26.
Zurück zum Zitat Tomlinson IP, Webb E, Carvajal-Carmona L et al (2008) A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 40(5):623–630. doi:10.1038/ng.111 PubMedCrossRef Tomlinson IP, Webb E, Carvajal-Carmona L et al (2008) A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 40(5):623–630. doi:10.​1038/​ng.​111 PubMedCrossRef
27.
Zurück zum Zitat Houlston RS, Webb E, Broderick P et al (2008) Meta-analysis of genome-wide association data identifies 4 novel susceptibility loci for colorectal cancer. Nat Genet (in press) Houlston RS, Webb E, Broderick P et al (2008) Meta-analysis of genome-wide association data identifies 4 novel susceptibility loci for colorectal cancer. Nat Genet (in press)
29.
Zurück zum Zitat Marchini J, Howie B, Myers S et al (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39(7):906–913. doi:10.1038/ng2088 PubMedCrossRef Marchini J, Howie B, Myers S et al (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39(7):906–913. doi:10.​1038/​ng2088 PubMedCrossRef
32.
33.
Zurück zum Zitat Wang GY, Lu CQ, Zhang RM et al (2008) The E-cadherin gene polymorphism 160C-> A and cancer risk: a HuGE review and meta-analysis of 26 case-control studies. Am J Epidemiol 167(1):7–14PubMedCrossRef Wang GY, Lu CQ, Zhang RM et al (2008) The E-cadherin gene polymorphism 160C-> A and cancer risk: a HuGE review and meta-analysis of 26 case-control studies. Am J Epidemiol 167(1):7–14PubMedCrossRef
34.
Zurück zum Zitat Qureshi HS, Linden MD, Divine G et al (2006) E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters. Am J Clin Pathol 125(3):377–385PubMed Qureshi HS, Linden MD, Divine G et al (2006) E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters. Am J Clin Pathol 125(3):377–385PubMed
Metadaten
Titel
Low penetrance breast cancer predisposition SNPs are site specific
verfasst von
Niall Mcinerney
Gabrielle Colleran
Andrew Rowan
Axel Walther
Ella Barclay
Sarah Spain
Angela M. Jones
Stephen Tuohy
Catherine Curran
Nicola Miller
Michael Kerin
Ian Tomlinson
Elinor Sawyer
Publikationsdatum
01.09.2009
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2009
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0235-7

Weitere Artikel der Ausgabe 1/2009

Breast Cancer Research and Treatment 1/2009 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.